V. S. Yudina

V. S. Yudina

Auto-generated profile, based on publicly available information

V. S. Yudina

Sechenov University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2022 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
AKAndrei Kaprin
Andrei Kaprin
OAO I Apolikhin
O I Apolikhin
АСА. В. Сивков
А. В. Сивков
OTOlga Trushina
Olga Trushina
ЕНЕ. Г. Новикова
Е. Г. Новикова
PLPlaton Lopukhov
Platon Lopukhov
Междисциплинарный подход к улучшению репродуктивного здоровья подростков и взрослого населения

23 June 2023 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
VYV. S. Yudina
V. S. Yudina
PLPlaton Lopukhov
Platon Lopukhov
AKAndrei Kaprin
Andrei Kaprin
OAO. I. Apolikhin
O. I. Apolikhin
OTOlga Trushina
Olga Trushina
NBN. I. Briko
N. I. Briko
The aim of the study was to analyze the incidence of malignant neoplasms of the organs of the reproductive system of the population aged 15 to 39 years within the Russian Federation.Material and methods. The data of specialized forms of state reporting No. 7 “Information on diseases of malignant neoplasms” and data of the Federal State Statistics Service of the Russian Federation on the size and sex and age composition of the population for the period from 2011 to 2021 were used.Results. In the dynamics of changes in the incidence of malignant neoplasms of the reproductive organs of the young population of the regions of the Russian Federation for the period from 2011 to 2021, multidirectional trends are observed. The highest incidence rates are in the Siberian and Far Eastern Federal Districts, namely in the Trans-Baikal Territory and the Magadan Region, the smallest – in the regions of the North Caucasian Federal District.Conclusions. Regional differences in incidence rates in the constituent entities of the Russian Federation were established, changes in trends were found for the age group of people from 15 to 39 years old, which may be associated with lifestyle changes, environmental factors, as well as improved detection of cancer.

10 November 2023 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
VYV. S. Yudina
V. S. Yudina
Relevance. The demographic situation in the Russian Federation over the past decades has been characterized by negative dynamics, while the two key indicators, the ratio of which affects this, are birth and death rates. Of particular interest in this case are malignant neoplasms (MNs) of the organs of the reproductive system, which can both affect the decline in fertility, especially when it comes to the age group under 40, and make a significant contribution to the structure of the population mortality.Аim. Analyze the changes in mortality rates from cancer of the reproductive organs among the population aged 15 to 39 years, their dynamics and structure in the Russian Federation for 2011–2020.Materials and methods. To calculate the indicators, an analysis was carried out of the data of the forms of the federal state static observation on the distribution of the deceased by sex, age groups and causes of death by Rosstat (FSN-C51) and statistical information on the age and sex composition of the population of the territories of the Russian Federation.Results. The highest «crude» mortality rates were noted in the Siberian and Far Eastern Federal Districts (5.04 (95% CI = 4.49–5.58) and 5.00 (95% CI = 4.09–5.90) per 100 thousand of the population, respectively), the smallest – n the regions of the North Caucasus Federal District (2.58 (95% CI = 2.06 - 3.11) per 100 thousand of the population). Significant gender differences were also identified. Female mortality from malignancies of the reproductive organs was significantly higher (the "crude” mortality rate among women was found to be 7.57 (95% CI = 7.22–7.92) versus 0.72 (95% CI = 0.61–0.82) among men per 100 thousand) due to the dominance of oncological lesions of the cervix and mammary gland at an earlier age.Conclusion. The identified features of the manifestations of mortality from cancer of the reproductive organs for various territories and population groups can serve as a rationale for strengthening the existing preventive measures, such as vaccination against HPV, as well as for developing new strategies aimed at improving the demographic situation.

19 November 2022 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
MYM. A. Yunusova
M. A. Yunusova
ELE. S. Lutsenko
E. S. Lutsenko
NTN. N. Tsapkova
N. N. Tsapkova
ABA. Yu. Brazhnikov
A. Yu. Brazhnikov
TST. S. Saltykova
T. S. Saltykova
VYV. S. Yudina
V. S. Yudina
Relevance. In a pandemic, studies on the duration of immunity in those who have recovered from COVID-19 and the formation of resistance to a new coronavirus infection are of particular importance.Target. To study the retention time of IgG in the blood serum of employees of a medical institution who recovered from a new coronavirus infection COVID-19.Materials and methods. The assessment of the timing of the formation of IgG was first carried out 3 weeks after the illness in employees of The National Medical Research Center for Otorhinolaryngology from April 2020 to December 2020. Further, the intervals for blood sampling to study the dynamics of antibodies to coronavirus infection were 3–4 weeks (9 blood samples for each ). Antibodies were examined by ELISA; immunological method for determining IgG (test system – "Vector Best", semi-quantitative analysis). Statistical processing of the study results was carried out using the SPSS-22 statistical software package and the OpenEpiver statistical calculator. 3.Results and discussion. The proportion of employees of a medical institution who recovered from COVID-19 was 39%, among them persons aged 36 to 55 years prevailed. It was found that class G immunoglobulins persist from seven months or more in 56.3% of those participating in the observation (the positivity coefficient is much higher than 1.2), in about 12.7% of those who had been ill, IgG in the blood serum persisted for about six months, in 11, 3% about three months. There were no statistically significant differences in the duration of immunity between men and women.Conclusion. A statistically significant direct relationship was found between age and the duration of immunity.

1 January 2026 in Direct Research Journal of Public Health and Environmental Technology
Verified
Journal Article
Open access
PDF file
LSLina Ephraim Sanga
Lina Ephraim Sanga
SVSergeevna Yudina Victoria
Sergeevna Yudina Victoria
ECEBUBE OLIVER CHUKWUNYERE
EBUBE OLIVER CHUKWUNYERE
Polycystic Ovary Syndrome (PCOS) is a prevalent endocrine and metabolic disorder associated with significant reproductive and cardiometabolic morbidity. Despite its global burden, community-level awareness in Sub-Saharan Africa remains under-researched. This study assessed the knowledge, awareness, information sources, and sociodemographic correlates of PCOS among women in Dar-es-Salaam, Tanzania. A community-based cross-sectional study was conducted among 405 women of reproductive age (15–49 years) in Dar-es-Salaam using a stratified multistage sampling technique. Data were collected via a structured questionnaire and analyzed using SPSS version 26. Chi-square tests were utilized to assess associations, with statistical significance set at p < 0.05. Participants demonstrated moderate-to-high awareness of core symptoms, including hormonal imbalance (78.6%), multiple ovarian cysts (82.1%), irregular menstruation (75.0%), and hirsutism (71.4%). However, significant knowledge gaps persisted regarding long-term complications; only 46.4% recognized the increased risk of type 2 diabetes, and 42.9% incorrectly believed PCOS does not affect fertility. While 78.6% were aware of lifestyle modifications as a management strategy, awareness of pharmacological treatments was low (e.g., metformin, 39.3%). Over half (57.1%) had previously received PCOS information, primarily from healthcare providers, educational institutions, and social media. Notably, 53.6% had never actively sought information about PCOS. Marital status showed no significant association with knowledge or awareness (p > 0.05). Women in Dar-es-Salaam possess adequate awareness of primary PCOS symptoms but lack critical knowledge regarding metabolic risks, fertility implications, and medical management. Public health interventions must pivot from basic symptom recognition to comprehensive reproductive and metabolic health education, leveraging primary care and regulated digital platforms.

24 September 2026 in Current Pediatrics
Verified
Journal Article
Open access
PDF file
IFIrina V. Fel’Dblyum
Irina V. Fel’Dblyum
KSKseniya A. Subbotina
Kseniya A. Subbotina
EUElena Vitalievna Uvarova
Elena Vitalievna Uvarova
NPNatalia A. Pekareva
Natalia A. Pekareva
EAEkaterina I. Alekseeva
Ekaterina I. Alekseeva
СГС. О. Голоднова
С. О. Голоднова
Background. Human papillomavirus (HPV) infection is a significant risk factor for the development of HPV-associated precancerous and malignant diseases. Recombinant adsorbed vaccine against HPV (types 6, 11, 16, and 18) has been developed in Russian Federation to prevent these conditions. Vaccine immunogenicity and safety have been studied in adults. Objective . The aim of the study is to evaluate the safety and immunogenicity of Russian recombinant adsorbed quadrivalent vaccine against HPV (types 6, 11, 16, and 18) in children aged 9–17 years in comparison to reference quadrivalent vaccine. Study design. Multicenter, randomized, double-blind, parallel-group, phase III clinical trial with a 1 : 1 participant allocation ratio. Methods. The study included healthy seronegative children aged 9–17 years. Study participants aged 9–13 years received either the investigational vaccine or the reference vaccine. Vaccine safety was assessed from April 2, 2024 to April 14, 2025, in all participants who received at least one vaccine dose (as-treated population). Any post-vaccination reactions and adverse events (AE) were recorded, their correlations with vaccination, severity, and duration were evaluated. The primary efficacy endpoint was the geometric mean titer ratio (GMT Ratio) of antibodies to HPV 1 month after full vaccination course (Per-Protocol (PP) population); additionally, the GMT Ratio was evaluated for every HPV type. Randomization was centralized and based on computer-generated list. Allocation concealment was ensured via the method of sequentially numbered, opaque, sealed envelopes. Results . A total of 705 AEs were registered during the study period, 426 of which were considered related to vaccination. No severe vaccination-related AEs were reported. The investigational vaccine demonstrated comparable immunogenicity to the reference drug across all four HPV types in both age cohorts. The seroconversion rate in PP population ranged from 97% to 100%. Higher GMT values were observed in participants aged 9–13 years compared to those aged 14–17 years. GMT values were higher in the investigational drug group in both age cohorts for HPV type 18. Conclusion . Favorable safety profile and adequate immunogenicity of the investigational vaccine were recorded compared to the reference vaccine in children aged 9–17 years. The obtained data suggest that the investigational vaccine is a promising drug for HPV-associated diseases prevention.